Two of the three monoclonal antibody treatments used to prevent COVID-19 patients from becoming severely sick don’t appear to be effective against the omicron coronavirus variant, The New York Times reported Dec. 21.
U.S. medical providers are seeing long delays in the delivery of medical supplies, according to a Dec. 17 Health Industry Distributors Association report.
Procter & Gamble on Dec. 17 recalled more than 30 aerosol spray hair care products, including many dry shampoos and dry conditioners, because of the detection of benzene, a cancer-causing agent, in some products.